TYROSINAMIDE, L-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C9H12N2O2
Molecular Weight	180.2038
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

N[C@@H](CC1=CC=C(O)C=C1)C(N)=O

InChI

InChIKey=PQFMNVGMJJMLAE-QMMMGPOBSA-N

InChI=1S/C9H12N2O2/c10-8(9(11)13)5-6-1-3-7(12)4-2-6/h1-4,8,12H,5,10H2,(H2,11,13)/t8-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C9H12N2O2
Molecular Weight	180.2038
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

PubMed

Title	Date	PubMed
In vitro selection of DNA aptamers that bind L-tyrosinamide.	2001 Oct	11557341
Probing the binding specificity of C-type lectins in vivo.	2003	14579569
Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.	2003 Feb 13	12570374
Immobilized DNA aptamers as target-specific chiral stationary phases for resolution of nucleoside and amino acid derivative enantiomers.	2004 Feb 15	14961733
Influence of alkyl group on amide nitrogen atom on fluorescence quenching of tyrosine amide and N-acetyltyrosine amide.	2004 Oct 1	15381308
Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene.	2005 Aug	16124759
CE with electrochemical detection for investigation of label-free recognition of amino acid amides by guanine-rich DNA aptamers.	2007 Aug	17674419
Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration.	2008 Mar	18290773
Microcalorimetrics studies of the thermodynamics and binding mechanism between L-tyrosinamide and aptamer.	2008 May 29	18457441
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.	2008 Sep 16	19238631
Synthesis, spectroscopic and structural elucidation of tyrosinamide hydrogensquarate monohydrate.	2009 Feb	18317871
Electropolymerized tyrosine-based thin films: selective cell binding via peptide recognition to novel electropolymerized biomimetic tyrosine RGDY films.	2009 Jan 1	18926794
Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.	2009 Jul	19304320
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474.	2009 Mar	19029224
Noncompetitive fluorescence polarization aptamer-based assay for small molecule detection.	2009 Sep 1	19630421
Design strategies of fluorescent biosensors based on biological macromolecular receptors.	2010	22205872
Glycan labeling strategies and their use in identification and quantification.	2010 Aug	20225063
Inhibition of Ser/Thr phosphatases induces capacitation-associated signaling in the presence of Src kinase inhibitors.	2010 Mar 12	20068039

Patents

Substance Class	Chemical Created by `admin` on `Fri Dec 15 17:16:40 GMT 2023` Edited by `admin` on `Fri Dec 15 17:16:40 GMT 2023`
Record UNII	05LU01CS4T
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TYROSINAMIDE, L-

Common Name

English

BENZENEPROPANAMIDE, .ALPHA.-AMINO-4-HYDROXY-, (.ALPHA.S)-

Systematic Name

English

TYROSINAMIDE

Common Name

English

TYRN

Common Name

English

AMIDATED L-TYROSINE

Common Name

English

L-TYROSINE AMIDE

Common Name

English

(S)-2-AMINO-3-(4-HYDOXYPHENYL)PROPANAMIDE

Systematic Name

English

TYROSINE AMIDE

Common Name

English

L-TYROSINAMIDE

Common Name

English

Code System Code Type Description

CAS

4985-46-0